Medical Nutrition Therapy Program for Pregnant Women With Diabetes
Gestational Diabetes, Type 2 Diabetes
About this trial
This is an interventional treatment trial for Gestational Diabetes focused on measuring gestational diabetes, medical nutrition therapy program, glucose monitoring, metabolic control, nutritional status, cost effectiveness
Eligibility Criteria
Inclusion Criteria:
- pregnant women with gestational diabetes (Freinkle´s classification: type A2 and B1) or pregestational type 2 diabetes.
- less than 30 weeks of gestation
- women who plan to attend their pregnancy at the institution (INPerIER)
Exclusion Criteria:
- women with type 1 pregestational diabetes or gestational diabetes type A1.
- women with multiple pregnancies
- women with renal or hepatic disease
- women who could not follow the dietary recommendations within the study
Sites / Locations
- Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
No Intervention
1
2
3
women in this group received usual medical treatment and counseling from a nutritionist and diabetes educator. They received a specific diet using carbohydrate counting (40-45% of carbohydrates)and a moderate energy restriction. Weight gain, adequacy of diet, results of the self glucose monitoring, and ketonuria were evaluated every two weeks. They also received education on diabetes, diet and glucose monitoring.
Women in this group received usual medical treatment and counseling from a nutritionist and diabetes educator. The diet they received was based on carbohydrate counting (40-45% of carbohydrates), but recommended only low-moderate glycemic index foods. Weight gain, adequacy of diet, results of the self glucose monitoring, and ketonuria were evaluated every two weeks. They also received education on diabetes, diet and glucose monitoring.
women in this group received the current hospital treatment. They did not receive any intervention except for the self glucose monitoring that they did every two weeks. Weight gain and the results of the self glucose monitoring, were evaluated every two weeks.